Patents by Inventor Jon Marc Rhoads

Jon Marc Rhoads has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11602551
    Abstract: The present invention provides the use of inosine in the treatment of a disease associated with Treg deficiency or Treg dysfunction, in particular immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX). In one embodiment of the invention, the inosine can be provided in the form of a bacterial strain that is capable of stimulating the production of inosine. Methods for stimulating the production of inosine in a subject using said strains are also provided, as are methods for the selection of a bacterial strain capable of stimulating inosine production in a subject.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: March 14, 2023
    Assignees: BioGaia AB, Board of Regents of the University of Texas System
    Inventors: Stefan Roos, Yuying Liu, Baokun He, Jon Marc Rhoads
  • Publication number: 20210060098
    Abstract: The present invention provides the use of inosine in the treatment of a disease associated with Treg deficiency or Treg dysfunction, in particular immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX). In one embodiment of the invention, the inosine can be provided in the form of a bacterial strain that is capable of stimulating the production of inosine. Methods for stimulating the production of inosine in a subject using said strains are also provided, as are methods for the selection of a bacterial strain capable of stimulating inosine production in a subject.
    Type: Application
    Filed: May 26, 2017
    Publication date: March 4, 2021
    Applicants: BioGaia AB, Board of Regents of the University of Texas System
    Inventors: Stefan Roos, Yuying Liu, Baokun He, Jon Marc Rhoads